Company Profile
Public information reviewedAptorum Group Ltd
Aptorum Group Limited, through its subsidiaries, a clinical stage biopharmaceutical company, engages in the discovery, development, and commercialization of therapeutic products to treat oncology and infectious diseases.
USNASDAQ: APM
Follow
More
- Public sources
- 1 reviewed
- Published leadership records
- 0
- Last reviewed
- Sep 17, 2026

